Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

Metastasis remains a pivotal characteristic of cancer and is the primary contributor to cancer-
associated mortality. Despite its significance, the mechanisms governing metastasis are not …

Objective The current treatment for hepatocellular carcinoma (HCC) to block angiogenesis
and immunosuppression provides some benefits only for a subset of patients with HCC, thus …

Hepatocellular carcinoma (HCC) is a malignant tumor with high mortality. This study aimed
to build a prognostic signature for HCC patients based on immune-related genes (IRGs) and …

Dihydroorotase (DHOase; EC 3.5. 2.3) is a zinc-dependent metalloenzyme that plays a key
role in the de novo pyrimidine biosynthesis pathway, catalyzing the reversible cyclization of …

Liver cancer is one of the most prevalent forms of cancer worldwide. A significant proportion
of patients with hepatocellular carcinoma (HCC) are diagnosed at advanced stages, leading …

Transposable elements (TEs) drive genome evolution and can affect gene expression
through diverse mechanisms. In breast cancer, disrupted regulation of TE sequences may …

Objective To investigate the alterations in serum metabolic profiles and early-stage
hepatocellular carcinoma (HCC) patient characteristics after radiofrequency ablation (RFA) …

Hepatocellular carcinoma (HCC), as a malignancy derived from liver tissue, is typically
associated with poor prognosis. Increasing evidence suggests a connection between …

Hepatocellular carcinoma (HCC) is a highly lethal liver cancer with significant heterogeneity,
which poses challenges in predicting prognosis and treatment outcomes. The impact of iron …